GlaxoSmithKline Annual Review 2004 - Cautionary statement

You are now accessing the company's Annual Report 2004.

GlaxoSmithKline plc is an English public limited company. Its shares are listed on the London Stock Exchange and the New York Stock Exchange.

This report is the Annual Report of the company for the full year ended 31st December 2004. The Annual Report was approved by the Board of Directors on 2nd March 2005.
A summary report on the year, the Annual Review is intended for the investor not needing the full detail of the Annual Report, is produced as a separate document. The Annual Review includes the joint statement by the Chairman and the Chief Executive Officer, a summary review of operations and summary financial statements.
The Annual Review is issued to all shareholders. The Annual Report is issued additionally to those shareholders who, by electing to receive the full Annual Report as well as the summary Annual Review, have indicated that they require more detailed financial reporting.

Cautionary statement regarding forward-looking statements
Forward-looking statements involve inherent risks and uncertainties. The Group cautions investors that a number of important factors including those in this document could cause actual results to differ materially from those contained in any forward-looking statement. Such factors include, but are not limited to, those discussed under 'Risk factors' in the Operating and Financial Review and Prospects section of the company's Annual Report for 2004 on Form 20-F filed with the US Securities and Exchange Commission.

View the GlaxoSmithKline 2004 Annual Report